Silverback Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $328k | 31k | 10.55 |
| 2024-09-30 | $476k | 33k | 14.50 |
| 2024-06-30 | $281k | 33k | 8.51 |
| 2024-03-31 | $513k | 50k | 10.22 |
| 2023-12-31 | $190k | 35k | 5.48 |
| 2023-09-30 | $130k | 34k | 3.78 |
| 2023-06-30 | $151k | 23k | 6.70 |
| 2023-03-31 | $19k | 2.9k | 6.50 |
| 2022-12-31 | $22k | 2.6k | 8.55 |
| 2022-06-30 | $6.0k | 1.5k | 4.01 |
| 2022-03-31 | $50k | 14k | 3.62 |
| 2021-12-31 | $1.2M | 172k | 6.77 |
| 2021-03-31 | $1.2M | 28k | 43.61 |